Sun, Dec 21, 2014, 2:01 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • mandoesit mandoesit May 8, 2013 2:38 PM Flag

    Zerenex Beats Rivals in Efficay, Safety & Administration Advantages.

    Seeking Alpha Keryx: A Small Biotech With Many Catalysts
    May 8 2013 By: George RHO
    Considering Zerenex's efficacy, safety, and administration advantages, versus the three main rivals in the market, as well as its unique ability to provide iron benefits, Keryx's ferric citrate has the potential to becomethe leading phosphate binder in the world. We believe the shares still have considerable upside potential, to be realized in the quarters and years ahead.

 
KERX
14.79+0.125(+0.85%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST